Results for:
April 24, 2024
How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies
In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success…
April 24, 2024
4 Key Components to a Winning Go-To-Market Strategy
Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It's more than just bringing a product to market—it's about aligning your offering with market needs, targeting the right audience, and positioning your brand for success. In this blog, we explore the essential steps and strategies necessary to…
June 15, 2023
Cell and Gene Therapy Funding Totaled $40 Billion in 2022, Growth Projected
Cell and gene therapy is attracting much attention these days and for good reason. For one, there has been a notable increase in the number of cell and gene therapies in clinical development over the past decade. In the United States alone there are over 1,000 cell and gene therapies in clinical development, and more…
June 13, 2023
It’s 2023: Where is the At-Home IVD Testing Market Now?
The Home IVD testing market is not new, but it had primarily been limited to glucose and pregnancy testing. COVID-19 testing has opened the door for home infectious disease testing and more. The market is detailed in Kalorama's latest report At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023 https://kaloramainformation.com/product/at-home-diagnostic-testing-markets-and-trends-covid-19-fob-glucose-hiv-and-other-tests-2023/The global Home IVD testing market was valued…
May 18, 2023
New Kalorama Report Pegs Clinical Lab Services Market at 168BN
The global market for clinical laboratory services grew to an estimated $168.3 billion during 2022. This is according to Kalorama's latest report on clinical lab services (https://kaloramainformation.com/product/clinical-laboratory-services-market-8th-edition/) The COVID-19 testing demand increased the market by more than $31 billion over the year. Besides the remarkable and continued growth in 2022 due to COVID-19 demand, there are a number of…
May 1, 2023
Despite Declines, COVID-19 Still a Large IVD Market
When a market declines in momentum, it's easy to forget that it still contributes to the overall market. This is the case with COVID-19. Testmakers are separating revenues to be sure investors know the parts of their business growing and declining and what part is related to the now-endemic disease. However, this belies the fact…
April 19, 2023
Six Trends to Watch in POC-IVD
Point of care IVD sales reached 45 billion dollars in 2022. This includes instruments - permanent and disposable, and associated reagents and supplies. Kalorama Information's latest report details this: https://kaloramainformation.com/product/the-worldwide-market-for-point-of-care-poc-diagnostic-tests-10th-edition/Point of care covers a variety of tests - some performed in a lab, some in a doctor's office, some in a patient's home that…
April 7, 2023
Hematology Grows, Driven by Decentralization
The global market for hematology testing, inclusive of analyzers/instruments and reagents, is valued at $5,655 million in 2022. This includes all commercial laboratory and hospital-based products, some research use products used in clinical laboratories, and OTC product sales (not test services). This is according to Kalorama's latest on hematology IVD. The report indicates that decentralized…
March 3, 2023
Still Room to Grow in Infectious Disease IVD
Per Kalorama Information's World Infectious Disease report: Opportunities for infectious disease testing products vary widely between the developed and developing countries, according to our most recent report on infectious disease world markets. With favorable access to a complete range of tests and the operation of advanced medical delivery systems that reach most residents and in spite of making…
February 6, 2023
Growth in Molecular Diagnostics, Beyond COVID-19
COVID-19 is not over, but test sales are clearly on the decline, and IVD companies for the most part have adopted a focus on other test areas to beat the negative trend. Abbot, Roche, Hologic and Quest are among the diagnostic testing companies that have reported 2022 results with COVID-19 losses softened by gains in…
January 23, 2023
Expect More Testing Performed at Physician Office Lab Venues: Report
The IVD market follows patients where technologies allow. There's no greater evidence for need for IVD product makers to find a market in physician office labs than the declining hospital bed count. With declining hospital bed in developed countries and slow growth in hospital bed volume even in developing nations, it makes sense that more…
January 11, 2023
NGS in Molecular Diagnostics
The first NGS system was approved for clinical use by the FDA only in 2013. Hence, the market segment is quite new, even though a significant industry exists for LDTs performed as testing services on NGS platforms by certified clinical labs. The current IVD market available in clinical sequencing consists largely of sales of NGS…
January 1, 1970
For The IVD Industry, COVID-19 is Still A Large Market
COVID-19 Testing Market Declines, But Holds Value in Endemic Phase: ReportThe global COVID-19 IVD market exceeded $29 billion in 2022, a figure consisting of immunoassay and molecular testing. That makes it one of the largest markets in IVD even as it becomes endemic. It is the largest single-disease infectious disease testing market, beating hepatitis and…